Tag: hydrocodone

Ask the Experts

Staying compliant with new DOT regulations

November 29, 2017

New DOT regulations add four opioids: hydrocodone, oxycodone, hydromorphone, and oxymorphone to the test panel. Our experts answer your questions.

Urine testing

Clarifying the changes in federal workplace drug testing & documentation

November 10, 2017

Changes to the federal drug testing panel and paperwork are forthcoming, but for now you should continue testing as usual.

Drugs & Alcohol

10 facts about opioids

October 10, 2017

We compiled the most recent data and headlines about substance abuse, addiction, overdose deaths, and health consequences of America's opioid crisis.

News

DEA proposal to curb production of prescription drugs

August 24, 2017

On August 7, 2017 the DEA published a proposal to limit the manufacturing of several controlled substances starting in 2018.

Illicit drugs

Fighting opioid prescription addiction

June 29, 2017

See how the CDC along with federal and state governments are working to combat the opioid epidemic in the U.S.

By the Numbers

Prescription misuse epidemic affects 7 in 10 employers

May 11, 2017

Data shows that 71% of employers are impacted by our country’s prescription drug epidemic. Employers want to help, yet many feel "unprepared."

News

Revisions to Federal workplace drug testing

February 10, 2017

HHS revised its mandatory guidelines to expand federal urine drug testing to include hydrocodone, hydromorphone, oxycodone, and oxymorphone.

News

Fentanyl in the news

June 29, 2016

The U.S. is experiencing a sharp increase in the abuse of fentanyl, a powerful synthetic opioid that is 50 to 100 times more potent than morphine.

News

White House addresses opioid abuse epidemic

February 29, 2016

President Obama announced his proposal to invest $1 billion in new mandatory funding to expand access to treatment for prescription drug abuse.

News

Drug testing trends video

August 14, 2015

A new video highlights key findings from the “Drug Testing Trends” session presented by Dr. Barry Sample at the annual DATIA conference. Watch now.